
    
      The BLOCk-CTI study is a prospective, multicenter, single blind, 1:1 randomized study. The
      study is designed to demonstrate that the safety and effectiveness of the Blazer®
      Open-Irrigated Ablation Catheter are non-inferior to the safety and effectiveness of the
      control catheters. In this study, the control catheters are open-irrigated radiofrequency
      ablation catheters that have received FDA market approval for the treatment of type 1 atrial
      flutter. (Biosense Webster ThermoCool® ablation catheters (NaviStar™, EZ Steer, or SF) or St.
      Jude Medical ablation catheters (Therapy™ Cool Path™ or Safire BLU™).
    
  